Skip to content

Garima Bhandari, DO

NPI 1578249785ActiveIndividual· Internal Medicine· Omaha, NE

Internal Medicine (DO) in Omaha, Nebraska, licensed in NE, with an NPI issued in June 2023. Part D covered 232 prescriptions written in 2024, 87% of them generic. Agepha Pharma Fz LLC was the largest of 2 companies reporting payments in 2025, $208.11 in all, mostly food and beverage.

Overview

NPI1578249785
StatusActive
Entity typeIndividual
CredentialDO
Sole proprietorNo
NPI issuedJun 22, 2023
Last updated in NPPESJun 22, 2023
Certified by providerJun 22, 2023

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000X9754NE

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Internal Medicine (NE)

Part D prescriptions in 2024

Prescriptions (claims)232 · 379 30-day fills
Patients43
Total drug cost$20,078
Generic share87% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$208.11 · 2 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Agepha Pharma Fz LLC$163.891
Astrazeneca Pharmaceuticals LP$44.221

What the 2025 payments were for

  • Food and Beverage$208.11 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine providers in Omaha

All Internal Medicine providers in Nebraska →